跳至主要内容
临床试验/NCT01379001
NCT01379001已完成不适用

Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI

Hebrew SeniorLife0 个研究点目标入组 60 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
主要终点
Cerebral blood flow

研究概览

简要总结

This research study will look at how medications affect the pattern of blood flow in the brain. This study will use a special type of MRI (magnetic resonance imaging) scan called perfusion MRI to make measurements of cerebral (brain) blood flow. The medications we will use in this study are scopolamine (commonly used to treat motion sickness), mecamylamine (used to treat high blood pressure), and donepezil (used to treat memory loss). Cognitive testing will also be obtained, and correlated with the blood flow patterns in the brain.

详细描述

Project Summary: This research project will investigate the value of combined pharmacologic manipulation and arterial spin-labeled perfusion MRI (pharmacologic ASL-pMRI) as an in vivo probe of cholinergic function. Methods to investigate cholinergic function in vivo are needed to better understand the role of acetylcholine in the physiology of the cerebral cortex, and in cognitive processes in health and in disease states. In this study, pharmacologic ASL-pMRI will be used to characterize the normal cerebral perfusion response to cholinergic manipulation in young healthy subjects. Cognitive measures will also be obtained and correlated with cerebral perfusion changes. Pharmacologic ASL-pMRI and cognitive testing will then be used to study how the cholinergic response is altered with normal aging and in delirium

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy volunteers

排除标准

  • Any neurological condition, such as brain tumor, history of stroke, seizure disorder, attention deficit disorder, normal pressure hydrocephalus, dementia, traumatic brain injury
  • Any major medical conditions, such a cancer, diabetes, glaucoma, prostate disease, uncontrolled hypertension
  • antihistamine use
  • tricyclic antidepressant use
  • presence of metal in body, including pacemaker, defibrillator, neurostimulator, metal implants, or foreign metal objects such as bullets or shrapnel.
  • anxiety or panic disorder
  • history of claustrophobia
  • pregnancy

研究组 & 干预措施

Older

Experimental

Older healthy controls, aged 65-80

干预措施: Donepezil (Drug)

Young

Experimental

Young healthy controls, aged 21-35

干预措施: Scopolamine (Drug)

Young

Experimental

Young healthy controls, aged 21-35

干预措施: Placebo (Drug)

Older

Experimental

Older healthy controls, aged 65-80

干预措施: Scopolamine (Drug)

Older

Experimental

Older healthy controls, aged 65-80

干预措施: Placebo (Drug)

结局指标

主要结局

Cerebral blood flow

时间窗: 3 hours

cerebral blood flow will be measured 3 hours after drug administration using Arterial spin-labeled perfusion MRI

次要结局

  • cognitive performance(4 hours)

研究者

发起方
Hebrew SeniorLife
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamara Fong

Assistant Scientist/Assistant Professor of Neurology

Hebrew SeniorLife

相似试验